Skip to main content
. 2019 Mar 8;60(1):14–24. doi: 10.1002/mus.26447

Figure 4.

Figure 4

Change from REGAIN baseline to week 130 in the open‐label extension study in MG‐ADL (A), QMG (B), MGC (C), and MG‐QOL15 (D) total scores (mean [95% CI]) by treatment arm over time (full analysis set). Patient numbers were not the same for each assessment. BL, baseline; CI, confidence interval; MG‐ADL, Myasthenia Gravis Activities of Daily Living; MGC, Myasthenia Gravis Composite scale; MG‐QOL15, Myasthenia Gravis Quality of Life 15; QMG, Quantitative Myasthenia Gravis scale.